India's pharma shipments: Brazil, Nigeria emerge as key export destinations; market expands to $20.48 billion
India's pharma shipments: Brazil, Nigeria emerge as key export destinations; market expands to $20.48 billion
Indian pharmaceutical exports are experiencing robust growth in emerging markets like Brazil and Nigeria, driven by increased healthcare access and demand for generics. Despite global economic headwinds, these nations are becoming crucial destinations, contributing significantly to India's overall pharma export expansion and strengthening its global market position.
Indian pharmaceutical exports are experiencing robust growth in emerging markets like Brazil and Nigeria, driven by increased healthcare access and demand for generics. Despite global economic headwinds, these nations are becoming crucial destinations, contributing significantly to India's overall pharma export expansion and strengthening its global market position.
Indian pharmaceutical exports are experiencing robust growth in emerging markets like Brazil and Nigeria, driven by increased healthcare access and demand for generics. Despite global economic headwinds, these nations are becoming crucial destinations, contributing significantly to India's overall pharma export expansion and strengthening its global market position. 
